| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2002 | Aberrant expression of cell-cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability | Lung, J. C.; Chu, J. S.; Yu, J. C.; Yue, C. T.; Lo, Y. L.; Shen, C. Y.; Wu, C. W. | Genes Chromosomes Cancer 34, 276-284 | | | |
| 2004 | Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade | Ding, S. L.; Sheu, L. F.; Yu, J. C.; Yang, T. L.; Chen, B. F.; Leu, F. J.; Shen, C. Y. | BRITISH JOURNAL OF CANCER 90, 1995-2001 | | | |
| 1998 | Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset) | Lo, Y. L.; Yu, J. C.; Huang, C. S.; Tseng, S. L.; Chang, T. M.; Chang, K. J.; Wu, C. W.; Shen, C. Y. | Int J Cancer 79, 580-587 | | | |
| 2004 | Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1 | Bau, D. T.; Fu, Y. P.; Chen, S. T.; Cheng, T. C.; Yu, J. C.; Wu, P. E.; Shen, C. Y. | Cancer Res 64, 5013-5019 | | | |
| 2005 | Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility | Cheng, T. C.; Chen, S. T.; Huang, C. S.; Fu, Y. P.; Yu, J. C.; Cheng, C. W.; Wu, P. E.; Shen, C. Y. | Int J Cancer 113, 345-353 | | | |
| 2005 | Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK | Lo, Y. L.; Yu, J. C.; Chen, S. T.; Yang, H. C.; Fann, C. S. J.; Mau, Y. C.; Shen, C. Y. | Int J Cancer 115, 276-283 | | | |
| 2007 | Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility | Lo, Y. L.; Yu, J. C.; Chen, S. T.; Hsu, G. C.; Mau, Y. C.; Yang, S. L.; Wu, P. E.; Shen, C. Y. | Carcinogenesis 28(5), 1079-1086 | | | |
| 2003 | Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility | Fu, Y. P.; Yu, J. C.; Cheng, T. C.; Lou, M. A.; Hsu, G. C.; Wu, C. Y.; Chen, S. T.; Wu, H. S.; Wu, P. E.; Shen, C. Y. | Cancer Res 63, 2440-2446 | | | |
| 2006 | Breast cancer risk associated with genotyping polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility | Yu, J. C.; Hsu, H. M.; Chen, S. T.; Hsu, G. C.; Huang, C. S.; Hou, M. F.; Fu, Y. P.; Cheng, T. C.; Wu, P. E.; Shen, C. Y. | J Biomed Sci 13, 419-432 | | | |
| 2007 | Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex | Hsu, H. M.; Wang, H. C.; Chen, S. T.; Hsu, G. C.; Shen, C. Y.; Yu, J. C. | Cancer Epidemiol Biomarkers Prev 16, 2024-2032 | | | |
| 1997 | Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia (T-ALL) | Batova, A.; Diccianni, M. B.; Yu, J. C.; Nobori, T.; Link, M. P.; Pullen, J.; Yu, A. L. | Cancer Res 57, 832-836 | | | |
| 2009 | Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility | Ding, S. L.; Yu, J. C.; Chen, S. T.; Hsu, G. C.; Kuo, S. J.; Lin, Y. H.; Wu, P. E.; Shen, C. Y. | CARCINOGENESIS 30, 43-49 | | | |
| 2005 | Genetic variants of myeloperoxidase and catechol-O-methyltransferase and Breast cancer risk | Lin, S. C.; Chou, Y. C.; Wu, M. H.; Wu, C. C.; Lin, W. Y.; Yu, C. P.; Yu, J. C.; You, S. L.; Chen, C. J.; Sun, C. A. | Eur J Cancer Prev 14, 257-261 | | | |
| 2007 | Genetic variation in the premature aging gene, WRN: a case-control study on breast cancer susceptibility | Ding, S. L.; Yu, J. C.; Chen, S. T.; Hsu, G. C.; Shen, C. Y. | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 16(2), 263-269 | | | |
| 2000 | Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis | Shen, C. Y.; Yu, J. C.; Lo, Y. L.; Kuo, C. H.; Yue, C. T.; Jou, Y. S.; Huang, C. S.; Lung, J. C.; Wu, C. W. | Cancer Res 60, 3884-3892 | | | |
| 2004 | High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity | Yang, T. L.; Su, Y. R.; Huang, C. S.; Yu, J. C.; Lo, Y. L.; Wu, P. E.; Su, Y. R.; Huang, C. S.; Yu, J. C.; Lo, Y. L.; Wu, P. E.; Shen, C. Y. | GENES CHROMOSOMES & CANCER 41, 250-256 | | | |
| 2006 | Hormonal and body-size factors in relation to breast cancer risk: A prospective study of 11,889 women in a low-incidence area | Wu, M. H.; Chou, Y. C.; Yu, J. C.; Yu, C. P.; Wu, C. C.; Chu, C. M.; Yang, T.; Lai, C. H.; Hsieh, C. Y.; You, S. L.; Chen, C. J.; Sun, C. A. | Ann Epidemiol 16, 223-229 | | | |
| 2001 | Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene | Cheng, C. W.; Wu, P. E.; Yu, J. C.; Huang, C. S.; Yue, C. T.; Wu, C. W.; Shen, C. Y. | Oncogene 20, 3814-3823 | | | |
| 2008 | Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan | Cheng, C. W.; Yu, J. C.; Huang, C. S.; Shieh, J. C.; Fu, Y. P.; Wang, H. W.; Wu, P. E.; Shen, C. Y. | BREAST CANCER RESEARCH AND TREATMENT 111, 145-155 | | | |
| 2012 | Structure-based design of cancer- targeting peptides for therapy and imaging | Wang, S. H.; Chen, I. J.; Chang, N. C.; Yu, A. L.; Wu, H. C.; Yu, H. M.; Chang, Y. J.; Lee, T. W.; Yu, J. C.; Lee, A. C-L; Yu, J. | NATURE BIOTECHNOLOGY | | | |
